Two major medical centers chasing some of the multi-faceted rewards of genomic sequencing – better informed prescribing decisions and potentially lower medical costs – are making slow but steady strides in rolling out nascent infrastructures for the project, according to key players in the initiatives who spoke at the Molecular Medicine Tri-Con meeting this week.